Protocol to identify biomarkers in patients with post-COVID condition using multi-omics and machine learning analysis of human plasma

STAR Protoc. 2024 Apr 27;5(2):103041. doi: 10.1016/j.xpro.2024.103041. Online ahead of print.

Abstract

Here, we present a workflow for analyzing multi-omics data of plasma samples in patients with post-COVID condition (PCC). Applicable to various diseases, we outline steps for data preprocessing and integrating diverse assay datasets. Then, we detail statistical analysis to unveil plasma profile changes and identify biomarker-clinical variable associations. The last two steps discuss machine learning techniques for unsupervised clustering of patients based on their inherent molecular similarities and feature selection to identify predictive biomarkers. For complete details on the use and execution of this protocol, please refer to Wang et al.1.

Keywords: Bioinformatics; Clinical Protocol; Metabolomics; Proteomics.